EUVIMEDEUVIMED entdecken
Leserbrief

Sustained measurable residual disease negativity or guaranteed survival time in multiple myeloma?

Xin Zhou iD, Ningning Shan

British Journal of Haematology · 08.11.2026

DOI: 10.1111/bjh.70949 ↗

Kurz gefasst

Leserbrief in der Zeitschrift British Journal of Haematology, online erschienen am 08.11.2026. Verfasst von Xin Zhou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The Second Qilu Hospital of Shandong University, Jinan, Shandong, China. Die Arbeit nennt 4 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, Shandong University Horizontal Research Projects.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Hematology, The Second Qilu Hospital of Shandong University, Jinan, Shandong, China.

ORCID-Profile: Xin Zhou

Förderung

  • Natural Science Foundation of Shandong Province
  • Shandong University Horizontal Research Projects

Zitieren

APA

Zhou, X., & Shan, N. (2026). Sustained measurable residual disease negativity or guaranteed survival time in multiple myeloma?. British Journal of Haematology. https://doi.org/10.1111/bjh.70949

Vancouver

Zhou X, Shan N. Sustained measurable residual disease negativity or guaranteed survival time in multiple myeloma?. British Journal of Haematology. 2026. doi:10.1111/bjh.70949

BibTeX
@article{Zhou2026,
  author = {Zhou, Xin and Shan, Ningning},
  title = {Sustained measurable residual disease negativity or guaranteed survival time in multiple myeloma?},
  journal = {British Journal of Haematology},
  year = {2026},
  doi = {10.1111/bjh.70949}
}
Kostenlos starten →